Leuven.Inc Entrepreneurscafé IBA (Ion Beam Applications)

Bringing the most advanced cancer treatment technologies to the market

IBA (Ion Beam Applications S.A.) started in 1986 as a spin-off of the UCL in Louvain-la-Neuve and is the technology leader in advanced cancer radiation therapy and diagnostic technologies. The company’s special expertise lies in the development of innovative proton therapy technologies, supplying the oncology world with equipment of unequalled precision. Proton therapy is the most advanced form of radiotherapy available today. IBA also focuses on the development and supply of dosimetry solutions for Quality Assurance of medical equipment and increased patient safety as well as particle accelerators for medical and industrial applications.

Headquartered in Louvain-la-Neuve and employing more than 1,000 people worldwide, IBA currently has installed systems across Europe, Asia and the US and is expanding into emerging markets.  More information can be found at: http://www.iba-worldwide.com/

Practical details

Date: Thursday April 2nd, 2015 (17h30 – 20h30)
Avenue J-E Lenoir, 6 - 1348 Louvain-La-Neuve 


17h00: Arrival participants
17h30: Welcome by Leuven.Inc
17h40: Challenges of the worldwide leader in proton therapy
Olivier Legrain, CEO IBA 
18h30: Q&A
18h45: Tour of the production hall
19h15: Reception and networking
20h30: Closing of the Café


Registration by Thursday March 25th, 2015, preferably via the online registration form (use the 'Register' button) or by email to admin@leuveninc.com (including all contact and invoice details).

Please note: Leuven.Inc Entrepreneurscafés are a members-only activity.

For organizational reasons, the number of participants will be limited. Company members (max. 2 persons/company) will have first priority to register till March 2nd.
After this date, individual members can register according to the 'first subscribe, first serve' principle.

After registration you will receive a confirmation and route description. 
May we kindly ask you to inform us in case you are not able to attend.

Subscribe to our newsletter

Stay tuned and get our news in your inbox: subscribe here.

Keep me informed
Follow us